Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China · Delayed Price · Currency is CNY 24.06
-1.54 (-6.02%)
Sep 11, 2026, 3:00 PM CST
SHA:688062 Market Cap
SHA:688062 has a market cap or net worth of 10.4 billion as of September 11, 2026. Its market cap has decreased by -47.61% in one year.
Market Cap
10.40B
Enterprise Value
11.24B
Revenue
873.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.06
ChartMarket Cap Chart
Since January 18, 2022, SHA:688062's market cap has increased from 9.79B to 10.40B, an increase of 6.27%. That is a compound annual growth rate of 1.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 10.40B | -32.29% |
| Dec 31, 2025 | 15.36B | 90.35% |
| Dec 31, 2024 | 8.07B | -38.21% |
| Dec 29, 2023 | 13.06B | 126.23% |
| Dec 30, 2022 | 5.77B | -41.02% |
| Jan 18, 2022 | 9.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sino Biological,Inc. | 11.26B |
| Tibet Cheezheng Tibetan Medicine | 11.20B |
| Chengdu Olymvax Biopharmaceuticals | 11.08B |
| Chengzhi | 11.01B |
| Jiangxi Fushine Pharmaceutical | 10.76B |
| Hualan Biological Vaccine | 10.53B |
| Nanjing Vazyme Biotech | 10.14B |
| InventisBio | 9.99B |